What We Offer:
Semaglutide
Semaglutide, the active ingredient in Ozempic and Wegovy, is a once-weekly injectable GLP-1 medication. GLP-1 drugs are approved for managing type 2 diabetes because they lower blood sugar and increase insulin levels. In addition to regulating blood sugar and insulin, these injections have also been shown to be highly effective for weight loss.
Tirzepatide
Tirzepatide, the active ingredient in Mounjaro and Zepbound, is a once-weekly injectable GLP-1 medication. GLP-1 therapies are approved for treating type 2 diabetes because they help reduce blood sugar and increase insulin production. Beyond these effects, research has shown that these injections are also highly effective for supporting weight loss.
HOW IT WORKS
GLP-1 medications support weight loss by mimicking a natural hormone in the body that helps regulate appetite, digestion, and blood sugar. These medications slow the rate at which the stomach empties, helping you feel full longer after eating. They also act on the brain’s appetite centers to reduce hunger and cravings, making it easier to control portion sizes and reduce overall calorie intake. Additionally, GLP-1s improve how the body responds to insulin and stabilize blood sugar levels, which can help reduce overeating driven by blood sugar fluctuations. Together, these effects make GLP-1 medications a powerful tool for sustainable weight loss when combined with healthy lifestyle habits.